Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

(2016) A. Waghmare et al.   BLOOD

BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation

(2016) Fiona L. Dignan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease

(2016) Richard L. Wasserman et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative

(2016) O.E. Beaird et al.   Transplant Infectious Disease

Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus

(2015) M Boukhvalova et al.   BONE MARROW TRANSPLANTATION

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

(2015) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

(2014) Roy F. Chemaly et al.   CLINICAL INFECTIOUS DISEASES

Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study

(2014) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit

(2013) N Lehners et al.   BONE MARROW TRANSPLANTATION

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections

(2013) D. P. Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

(2013) Yae-Jean Kim et al.   JOURNAL OF INFECTIOUS DISEASES

Motavizumab Treatment of Infants Hospitalized With Respiratory Syncytial Virus Infection Does Not Decrease Viral Load or Severity of Illness

(2013) Octavio Ramilo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

(2012) Hans H. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus

(2012) V. Luchsinger et al.   CLINICAL INFECTIOUS DISEASES

An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus Infection

(2012) Roy F. Chemaly et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab

(2011) Qing Zhu et al.   JOURNAL OF INFECTIOUS DISEASES

The other side of immunoglobulin G: suppressor of inflammation

(2010) S. Aschermann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

(2009) J. T. Schiffer et al.   HAEMATOLOGICA

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES